These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19108654)

  • 21. High throughput microsomal stability assay for insoluble compounds.
    Di L; Kerns EH; Li SQ; Petusky SL
    Int J Pharm; 2006 Jul; 317(1):54-60. PubMed ID: 16621364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.
    Rousu T; Pelkonen O; Tolonen A
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):843-55. PubMed ID: 19224530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization and validation of a liquid chromatography tandem mass spectrometry (LC/MSn) method for analysis of corticosteroids in bovine liver: evaluation of Keyhole Limpet beta-glucuronidase/sulfatase enzyme extract.
    Croes K; Goeyens L; Baeyens W; Van Loco J; Impens S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):635-44. PubMed ID: 19211313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-Rank: a robust algorithm for small molecule identification using tandem mass spectrometry.
    Mylonas R; Mauron Y; Masselot A; Binz PA; Budin N; Fathi M; Viette V; Hochstrasser DF; Lisacek F
    Anal Chem; 2009 Sep; 81(18):7604-10. PubMed ID: 19702277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico modeling of nonspecific binding to human liver microsomes.
    Gao H; Yao L; Mathieu HW; Zhang Y; Maurer TS; Troutman MD; Scott DO; Ruggeri RB; Lin J
    Drug Metab Dispos; 2008 Oct; 36(10):2130-5. PubMed ID: 18606744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens.
    Caldwell GW
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):30-41. PubMed ID: 19649835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of overall in vitro microsomal stability of drug candidates based on molecular modeling and support vector machines. Case study of novel arylpiperazines derivatives.
    Ulenberg S; Belka M; Król M; Herold F; Hewelt-Belka W; Kot-Wasik A; Bączek T
    PLoS One; 2015; 10(3):e0122772. PubMed ID: 25826401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects.
    Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2125-38. PubMed ID: 19517478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internal standard response variations during incurred sample analysis by LC-MS/MS: Case by case trouble-shooting.
    Tan A; Hussain S; Musuku A; Massé R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3201-9. PubMed ID: 19733134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a Dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates.
    Alelyunas YW; Liu R; Pelosi-Kilby L; Shen C
    Eur J Pharm Sci; 2009 May; 37(2):172-82. PubMed ID: 19429424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry.
    Berna M; Ackermann B
    Anal Chem; 2009 May; 81(10):3950-6. PubMed ID: 19388669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assays for the quantification of melphalan and its hydrolysis products in human plasma by liquid chromatography-tandem mass spectrometry.
    Mirkou A; Vignal B; Cohen S; Guillaumont M; Glehen O; Guitton J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3089-96. PubMed ID: 19674945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of uremic analytes in hemodialysate and their structural elucidation from accurate mass maps generated by a multi-dimensional liquid chromatography/mass spectrometry approach.
    Godfrey AR; Williams CM; Dudley E; Newton RP; Willshaw P; Mikhail A; Bastin L; Brenton AG
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3194-204. PubMed ID: 19718779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination and identification, according to European Union Decision 2002/657/EC, of malachite green and its metabolite in fish by liquid chromatography-tandem mass spectrometry using an optimized extraction procedure and three-way calibration.
    Arroyo D; Ortiz MC; Sarabia LA; Palacios F
    J Chromatogr A; 2009 Jul; 1216(29):5472-82. PubMed ID: 19535083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A liquid chromatography/tandem mass spectrometry method for detecting UGT-mediated bioactivation of drugs as their N-acetylcysteine adducts in human liver microsomes.
    Harada H; Endo T; Momose Y; Kusama H
    Rapid Commun Mass Spectrom; 2009 Mar; 23(5):564-70. PubMed ID: 19177506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Tao Y; Wang Y; Yuan Z
    Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2026-34. PubMed ID: 19504544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of drug bioavailability in humans using immobilized artificial membrane phosphatidylcholine column chromatography and in vitro hepatic metabolic clearance.
    Shin BS; Yoon CH; Balthasar JP; Choi BY; Hong SH; Kim HJ; Lee JB; Hwang SW; Yoo SD
    Biomed Chromatogr; 2009 Jul; 23(7):764-9. PubMed ID: 19296531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method.
    Rijk JC; Bovee TF; Wang S; Van Poucke C; Van Peteghem C; Nielen MW
    Anal Chim Acta; 2009 Apr; 637(1-2):305-14. PubMed ID: 19286044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
    Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
    J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.